Dr. Taha Gholipour, MD

Dr. Gholipour practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Gholipour's NPI, 1801159611, was assigned on June 18, 2012. Dr. Gholipour graduated from Tehran University of Medical Sciences School of Medicine in 2008. Dr. Gholipour holds California license C187602.

Dr. Gholipour's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Gholipour's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Gholipour is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Gholipour to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gholipour practices, 2 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Gholipour's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Gholipour is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Gholipour's licenses on file in 5 states: California, District of Columbia, Maryland, Virginia and Massachusetts.

Dmand AI lists alzheimer's disease, epilepsy, muscle weakness and seizures among the conditions Dr. Gholipour treats.

CMS data shows 347 Medicare services from Dr. Gholipour across 8 procedure codes in 2024, for 161 Medicare patients. Medicare paid $41,520 for them.

CMS counts 161 Medicare patients who saw Dr. Gholipour in 2024. The largest group is under 65, with 56 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gholipour's median patient age at 41, with 53% women.

In 2024, Dr. Gholipour wrote 182 Medicare Part D claims for 46 patients. 80% of them were for generic drugs. CMS names the drug for 106 of them, across 4 drugs with 11 or more claims each, at $30,236 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

Dr. Gholipour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gholipour as offering telehealth.

Dmand AI links 33 papers to Dr. Gholipour, published from 2011 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Magnetic Resonance Imaging, Seizures and Epilepsy. Dr. Gholipour has published most often in Epilepsia. Dr. Gholipour's most frequent co-authors are William D. Gaillard, Nathan Cohen, MD and Chima Obioma Oluigbo, MD.

CMS Open Payments shows 43 general payments to Dr. Gholipour from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 66% of the total. UCB, Inc. paid the most, $3,159.

Dmand AI lists 1 award for Dr. Gholipour, most recently American Epilepsy Society Research Training Award in 2017.

Dr. Gholipour graduated from Tehran University of Medical Sciences School of Medicine in 2008. Dr. Gholipour is a member of AAN and AES.

Dr. Gholipour is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.